What is the share price of Medico Remedies Ltd (MEDICO) today?
The share price of MEDICO as on 5th December 2025 is ₹53. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Medico Remedies Ltd (MEDICO) share?
The past returns of Medico Remedies Ltd (MEDICO) share are- Past 1 week: 6.62%
- Past 1 month: 7.12%
- Past 3 months: 34.95%
- Past 6 months: 1.58%
- Past 1 year: 12.02%
- Past 3 years: -14.70%
- Past 5 years: 120.33%
What are the peers or stocks similar to Medico Remedies Ltd (MEDICO)?
The peers or stocks similar to Medico Remedies Ltd (MEDICO) include:What is the market cap of Medico Remedies Ltd (MEDICO) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Medico Remedies Ltd (MEDICO) is ₹442.47 Cr as of 5th December 2025.What is the 52 week high and low of Medico Remedies Ltd (MEDICO) share?
The 52-week high of Medico Remedies Ltd (MEDICO) is ₹79.83 and the 52-week low is ₹37.18.What is the PE and PB ratio of Medico Remedies Ltd (MEDICO) stock?
The P/E (price-to-earnings) ratio of Medico Remedies Ltd (MEDICO) is 43.85. The P/B (price-to-book) ratio is 7.08.Which sector does Medico Remedies Ltd (MEDICO) belong to?
Medico Remedies Ltd (MEDICO) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Medico Remedies Ltd (MEDICO) shares?
You can directly buy Medico Remedies Ltd (MEDICO) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Medico Remedies Ltd
MEDICO Share Price
53.000.60% (-0.32)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
MEDICO Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
MEDICO Performance & Key Metrics
MEDICO Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 39.05 | 7.08 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.94 | 5.83 | 0.58% |
MEDICO Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
MEDICO Company Profile
Medico Remedies is engaged in the manufacturing of allopathic pharmaceutical preparations
SUNPHARMA
PE Ratio
39.92
39.92
1Y Return
1.01%
1.01%
Buy Reco %
91.67
91.67
TORNTPHARM
PE Ratio
67.21
67.21
1Y Return
13.21%
13.21%
Buy Reco %
76.92
76.92
CIPLA
PE Ratio
23.30
23.30
1Y Return
1.34%
1.34%
Buy Reco %
70.00
70.00
DRREDDY
PE Ratio
18.81
18.81
1Y Return
5.10%
5.10%
Buy Reco %
41.94
41.94
LUPIN
PE Ratio
29.12
29.12
1Y Return
0.46%
0.46%
Buy Reco %
72.22
72.22
MEDICO Forecast
MEDICO Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
MEDICO
MEDICO
Income
Balance Sheet
Cash Flow
Annual Normal View
MEDICO Income Statement
MEDICO Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 54.78 | 61.94 | 99.59 | 90.74 | 123.42 | 123.05 | 144.39 | 147.05 | 153.63 | 175.78 | ||||||||||
Raw Materials | 38.30 | 45.96 | 80.34 | 70.81 | 90.69 | 87.55 | 106.05 | 107.87 | 113.49 | 156.37 | ||||||||||
| Power & Fuel Cost | 1.05 | 1.42 | 1.73 | 1.83 | 1.91 | 2.29 | 2.47 | 2.55 | 2.92 | |||||||||||
| Employee Cost | 4.42 | 3.89 | 3.32 | 3.83 | 4.50 | 5.41 | 5.68 | 5.92 | 6.28 | |||||||||||
| Selling & Administrative Expenses | 4.02 | 4.78 | 6.10 | 7.72 | 10.60 | 11.20 | 11.92 | 6.49 | 10.84 | |||||||||||
| Operating & Other expenses | 2.92 | 1.50 | 3.44 | 1.60 | 9.45 | 7.24 | 4.70 | 9.18 | 2.41 | |||||||||||
EBITDA | 4.07 | 4.39 | 4.66 | 4.95 | 6.27 | 9.36 | 13.57 | 15.04 | 17.69 | 19.41 | ||||||||||
| Depreciation/Amortization | 1.05 | 1.00 | 1.51 | 1.66 | 1.65 | 2.22 | 2.72 | 2.88 | 3.03 | 3.03 | ||||||||||
| PBIT | 3.02 | 3.39 | 3.15 | 3.29 | 4.62 | 7.14 | 10.85 | 12.16 | 14.66 | 16.38 | ||||||||||
| Interest & Other Items | 1.33 | 1.52 | 0.98 | 1.06 | 0.92 | 0.66 | 0.75 | 0.82 | 1.16 | 1.29 | ||||||||||
| PBT | 1.69 | 1.87 | 2.17 | 2.23 | 3.70 | 6.48 | 10.10 | 11.34 | 13.50 | 15.09 | ||||||||||
| Taxes & Other Items | 0.06 | 0.65 | 0.61 | 0.58 | 1.11 | 1.67 | 2.86 | 3.05 | 3.41 | 3.76 | ||||||||||
| Net Income | 1.63 | 1.22 | 1.56 | 1.65 | 2.59 | 4.81 | 7.24 | 8.29 | 10.09 | 11.33 | ||||||||||
| EPS | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.07 | 1.00 | 1.22 | 1.37 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MEDICO Company Updates
MEDICO Stock Peers
MEDICO Past Performance & Peer Comparison
MEDICO Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Medico Remedies Ltd | 43.85 | 7.08 | — |
| Sun Pharmaceutical Industries Ltd | 39.92 | 6.02 | 0.88% |
| Torrent Pharmaceuticals Ltd | 67.21 | 16.92 | 0.84% |
| Cipla Ltd | 23.30 | 3.93 | 1.05% |
MEDICO Stock Price Comparison
Compare MEDICO with any stock or ETFCompare MEDICO with any stock or ETF
MEDICO
MEDICO Holdings
MEDICO Shareholdings
MEDICO Promoter Holdings Trend
MEDICO Promoter Holdings Trend
Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has decreased by 2.41%
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
MEDICO Institutional Holdings Trend
MEDICO Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
MEDICO Shareholding Pattern
MEDICO Shareholding Pattern
MEDICO Shareholding History
MEDICO Shareholding History
Foreign Institutions
smallcases containing MEDICO stock
smallcases containing MEDICO stock
Looks like this stock is not in any smallcase yet.
MEDICO Events
MEDICO Events
MEDICO Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
MEDICO has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
MEDICO Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
MEDICO has not given any dividends in last 5 years
MEDICO Dividends
MEDICO Dividends
Hmm, looks like data is unavailable here. Please come back after some timeMEDICO Stock News & Opinions
MEDICO Stock News & Opinions
Articles & Videos
Earnings
Medico Remedies standalone net profit rises 65.81% in the September 2025 quarter
Net profit of Medico Remedies rose 65.81% to Rs 2.57 crore in the quarter ended September 2025 as against Rs 1.55 crore during the previous quarter ended September 2024. Sales rose 33.77% to Rs 52.64 crore in the quarter ended September 2025 as against Rs 39.35 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales52.6439.35 34 OPM %5.176.12 - PBDT4.202.88 46 PBT3.472.13 63 NP2.571.55 66 Powered by Capital Market - Live
2 weeks agoCapital Market - Live
Corporate
Medico Remedies to table results
Medico Remedies will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Medico Remedies wins export order from PROMESE/CAL, Dominican Republic
Medico Remedies has secured government supply order for USD 1,116,517 to supply to PROMESE/CAL, Dominican Republic. PROMESE/CAL (Programa de Medicamentos Esenciales y Central de Log'stica) is the program responsible for the centralized purchase and distribution of medicines, health supplies and laboratory reagents that meets the demand of the National Public Health System in the Country of Dominican Republic. Medico Remedies has secured the order to supply tablets, capsules and dry syrups to PROMESE/CAL and will complete the supply of the full order within 3 months. Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Earnings
Medico Remedies standalone net profit rises 15.19% in the June 2025 quarter
Net profit of Medico Remedies rose 15.19% to Rs 1.82 crore in the quarter ended June 2025 as against Rs 1.58 crore during the previous quarter ended June 2024. Sales rose 24.19% to Rs 38.25 crore in the quarter ended June 2025 as against Rs 30.80 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales38.2530.80 24 OPM %7.409.12 - PBDT3.212.92 10 PBT2.442.17 12 NP1.821.58 15 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Medico Remedies AGM scheduled
Medico Remedies announced that the Annual General Meeting(AGM) of the company will be held on 8 September 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Medico Remedies announces board meeting date
Medico Remedies will hold a meeting of the Board of Directors of the Company on 8 August 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Medico Remedies standalone net profit rises 40.00% in the March 2025 quarter
Net profit of Medico Remedies rose 40.00% to Rs 4.34 crore in the quarter ended March 2025 as against Rs 3.10 crore during the previous quarter ended March 2024. Sales declined 0.05% to Rs 41.30 crore in the quarter ended March 2025 as against Rs 41.32 crore during the previous quarter ended March 2024. For the full year,net profit rose 21.71% to Rs 10.09 crore in the year ended March 2025 as against Rs 8.29 crore during the previous year ended March 2024. Sales rose 4.15% to Rs 150.94 crore in the year ended March 2025 as against Rs 144.92 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales41.3041.32 0 150.94144.92 4 OPM %16.1511.25 -9.948.91 - PBDT6.474.98 30 16.5314.22 16 PBT5.704.24 34 13.5011.34 19 NP4.343.10 40 10.098.29 22 Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Medico Remedies announces board meeting date
Medico Remedies will hold a meeting of the Board of Directors of the Company on 8 May 2025.Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Medico Remedies wins order of USD 1.9 million from Dominican Republic
Medico Remedies has secured government supply order for USD 1.9 million to supply to Dominican Republic (PROMESE/CAL). PROMESE/CAL (Programa de Medicamentos Esenciales y Central de Log'stica) is the program responsible for the centralized purchase and distribution of essential medicines for the public health sector, including pharmaceuticals in Dominican Republic. Medico Remedies has won the order to supply tablets, capsules and dry syrups to PROMESE/CAL and will complete the supply of the full order within 3 months.Powered by Capital Market - Live
7 months agoCapital Market - Live
Spotlight
Medico Remedies gains after securing Rs 16-cr supply order
The company will supply tablets, capsules, and dry syrups, with the completion expected within three months. Medico Remedies is principally engaged in the pharmaceutical business. The company's net profit climbed 80.7% to Rs 2.62 crore on a 32.7% rise in net sales to Rs 39.49 crore in Q3 FY25 over Q3 FY24.Powered by Capital Market - Live
7 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 11.11%, vs industry avg of 10.03%
Over the last 5 years, market share stayed at 0.04%
Over the last 5 years, net income has grown at a yearly rate of 43.64%, vs industry avg of 20.02%